In the clinical pharmacological study in healthy postmenopausal women, it was suggested that anastrozole 1mg might produce greater clinical efficacy in comparison with 0.5mg. In addition ...

The study was a multicentre, randomised, non-blinded, parallel-group trial of 0.5 and 1mg/day of anastrozole and approved by the Institutional Review Board in each of the 30 participating centres.